Remote Patient Monitoring

Business

Intraco Limited Insiders Show Confidence with Net Stock Purchases Over Past Year

Insiders at Singapore-listed Intraco Limited (SGX:I06) have been net buyers of the company's shares over the last twelve months, with the Executive Chairman making a notable purchase. While insider activity is not a standalone signal, it adds a layer of context for shareholders monitoring alignment between management and investors.

Jan 31, 2026

Business

Dolby Laboratories: A Sound Investment or Muted Growth? Analysts Weigh In on Stock's Valuation Gap

Dolby Laboratories (DLB) shares, closing at $64.19, present a complex picture for investors. While short-term momentum shows signs of improvement, longer-term returns have lagged, sparking debate over whether the audio technology pioneer is fundamentally undervalued or facing structural headwinds.

Jan 31, 2026

Business

LVMH Shares Show Signs of Life Amid Broader Slump: Is the Luxury Giant Undervalued?

LVMH's recent 0.8% single-day gain to €546.9 offers a glimmer of hope after a period of weaker performance, sparking debate among analysts over whether the market is underestimating the luxury conglomerate's long-term resilience and global footprint.

Jan 30, 2026

Business

Beyond the Price Tag: One Sub-$50 Stock with Potential, Two Raising Red Flags

While stocks priced between $10 and $50 can offer an appealing mix of accessibility and relative maturity, savvy investors know the sticker price is just the beginning. We examine one company in this range that appears poised for growth and two where the fundamentals warrant a closer, more cautious look.

Jan 30, 2026

Business

Beyond the Megacaps: Three Russell 2000 Stocks Poised for Growth

While market attention remains fixated on tech giants, the Russell 2000 index harbors promising, lesser-known companies. We examine three firms with distinct competitive advantages in environmental services, digital health, and private markets.

Jan 30, 2026

Business

Riding the Rollercoaster: Two High-Volatility Stocks with Strong Foundations, and One to Sidestep

Market volatility presents both risk and opportunity. We analyze two fundamentally sound yet turbulent stocks that may reward the patient, and flag one whose wild swings are best left to speculators.

Jan 30, 2026

Business

Geron Sees Price Target Cut to $3 by TD Cowen Ahead of Q4, But Buy Rating Stays

Analyst Tara Bancroft of TD Cowen lowered the firm's price target on Geron Corporation (GERN) from $4 to $3, maintaining a Buy rating ahead of the biotech's fourth-quarter results. The move reflects a model update as the company navigates mixed commercial progress for its blood cancer drug RYTELO.

Jan 30, 2026

Business

GE HealthCare Technologies Gains Analyst Favor, 2026 Outlook Brightens on Market Recovery

Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.

Jan 30, 2026

Business

DexCom's Strong Q4 Preliminary Results and Ambitious 2026 Outlook Fuel Investor Optimism

DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.

Jan 30, 2026

Business

Edwards Lifesciences Gains Analyst Favor as Renewed Growth Cycle Takes Hold

Wall Street analysts are raising price targets on Edwards Lifesciences, citing a renewed growth cycle driven by TAVR expansion and a strong product pipeline, positioning the medical device maker as a favored pick.

Jan 30, 2026

Business

Insulet's Stock Slump: A Buying Opportunity or a Sign of Deeper Trouble?

Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.

Jan 30, 2026

Business

FDA Greenlights Spectrum Dynamics' AI-Powered Imaging Platform, Boosting Nuclear Medicine Precision

The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.

Jan 30, 2026

World

Islamic State Claims Responsibility for Coordinated Assault on Niamey Airport

The Islamic State group has claimed a surprise attack on the international airport in Niger's capital, Niamey, causing material damage and wounding soldiers, according to a monitoring group. The assault marks the latest in a series of high-profile strikes by the jihadist network in the Sahel nation.

Jan 30, 2026

Business

Novo Nordisk's Wegovy Pill Sees Strong Uptake with Over 26,000 Prescriptions in Second Week

Newly launched oral weight-loss drug Wegovy from Novo Nordisk recorded more than 26,000 U.S. prescriptions in its second full week, signaling robust early demand as competition with Eli Lilly intensifies.

Jan 30, 2026

Business

Align Technology Doubles Down on Southeast Asia, Betting on Digital Dentistry to Fuel Growth

Align Technology is accelerating its expansion in Southeast Asia with new product launches and affordability programs, a strategic pivot as the company navigates competitive pressures and seeks to reignite investor confidence amid a challenging stock performance.

Jan 30, 2026

Business

Dynatrace Stock Plunge: A Buying Opportunity or a Value Trap?

Dynatrace shares have tumbled over 34% in the past year, significantly underperforming the broader software sector. A deep dive into valuation metrics, including discounted cash flow and peer comparisons, suggests the stock may be trading at a substantial discount. We examine the numbers and the narrative shaping investor sentiment.

Jan 30, 2026

Business

Penguin Solutions Emerges from Rebrand: Undervalued AI Play or Overpriced Gamble?

Following its strategic rebrand from SMART Global Holdings, Penguin Solutions (PENG) is positioning itself at the forefront of AI and high-performance computing infrastructure. Yet, its stock tells a complex story of short-term volatility against long-term potential, raising questions about its true valuation in a heated market.

Jan 30, 2026

World

German Authorities Crack Down on Alleged Arms Component Smuggling Ring to Russia

German federal prosecutors have arrested five individuals accused of operating a sophisticated smuggling network that allegedly funneled millions of euros worth of dual-use goods to Russian defense firms, in violation of EU sanctions imposed after the invasion of Ukraine.

Feb 2, 2026

Business

NuScale Power's SMR Bet: A Path to Wealth or a Nuclear Mirage?

NuScale Power holds a unique regulatory approval for its small modular reactor technology, positioning it at the forefront of a potential nuclear energy shift. Yet, with no commercial deployments and a canceled flagship project, investors face a high-stakes gamble between revolutionary disruption and fading promise.

Feb 2, 2026

Business

Conagra Bets on Protein-Packed Breakfast Bowls in Bid to Revitalize Frozen Food Sales

Conagra Brands launches Banquet MEGA Breakfast Bowls, a high-protein frozen line using a novel steaming method, signaling a strategic push into convenience-focused breakfast and testing investor appetite for its turnaround narrative.

Feb 2, 2026